マイコプラズマ試験の世界市場分析:製品別、技術別(PCR、ELISA、直接アッセイ、微生物培養技術)、用途別(細胞株、ウイルス、生産終了細胞試験)、エンドユーザー別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Mycoplasma Testing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing R&D investments in life sciences
3.2.2 Rising government support towards pharmaceutical and biotechnology industries
3.2.3 Rising cell culture contamination
3.3 Market Restraint Analysis
3.3.1 High cost of research in cell biology
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.4.2 Key opportunities prioritized, by technology
3.4.3 Key opportunities prioritized, by application
3.4.4 Key opportunities prioritized, by end-use
3.5 Mycoplasma Testing – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Industry Analysis – Porter’s
3.7 Competitive Landscape: Market Position Analysis, 2016
Chapter 4 Mycoplasma Testing: Product Estimates & Trend Analysis
4.1 Mycoplasma Testing Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments market estimate & forecast, 2014 – 2025 (USD Million)
4.3 Kits & Reagents
4.3.1 Kits & reagents market estimate & forecast, 2014 – 2025 (USD Million)
4.3.2 PCR Assays
4.3.2.1 PCR assays market estimate & forecast, 2014 – 2025 (USD Million)
4.3.3 Nucleic Acid Detection Kits
4.3.3.1 Nucleic acid detection kits market estimate & forecast, 2014 – 2025 (USD Million)
4.3.4 Stains
4.3.4.1 Stains market estimate & forecast, 2014 – 2025 (USD Million)
4.3.5 Standards & Controls
4.3.5.1 Standards & controls market estimate & forecast, 2014 – 2025 (USD Million)
4.3.6 Others
4.3.6.1 Others market estimate & forecast, 2014 – 2025 (USD Million)
4.4 Services
4.4.1 Services market estimate & forecast, 2014 – 2025 (USD Million)
Chapter 5 Mycoplasma Testing: Technology Estimates & Trend Analysis
5.1 Mycoplasma Testing market: Technology movement analysis
5.2 PCR
5.2.1 PCR market estimate & forecast, 2014 – 2025 (USD Million)
5.3 ELISA
5.3.1 ELISA market estimate & forecast, 2014 – 2025 (USD Million)
5.4 Direct Assay
5.4.1 Direct assay market estimate & forecast, 2014 – 2025 (USD Million)
5.5 Indirect Assay
5.5.1 Indirect assay market estimate & forecast, 2014 – 2025 (USD Million)
5.6 Microbial Culture Techniques
5.6.1 Microbial culture techniques market estimate & forecast, 2014 – 2025 (USD Million)
5.7 Enzymatic Methods
5.7.1 Enzymatic methods market estimate & forecast, 2014 – 2025 (USD Million)
Chapter 6 Mycoplasma Testing: Application Estimates & Trend Analysis
6.1 Mycoplasma Testing Market: Application Movement Analysis
6.2 Cell Line Testing
6.2.1 Cell line testing market estimate & forecast, 2014 – 2025 (USD Million)
6.3 Virus Testing
6.3.1 Virus testing market estimate & forecast, 2014 – 2025 (USD Million)
6.4 End of Production Cells Testing
6.4.1 End of production cells testing market estimate & forecast, 2014 – 2025 (USD Million)
6.5 Others
6.5.1 Others market estimate & forecast, 2014 – 2025 (USD Million)
Chapter 7 Mycoplasma Testing: End-Use Estimates & Trend Analysis
7.1 Mycoplasma Testing Market: End-Use Movement Analysis
7.2 Academic Research Institutes
7.2.1 Academic research institutes market estimate & forecast, 2014 – 2025 (USD Million)
7.3 Cell Banks
7.3.1 Cell banks market estimate & forecast, 2014 – 2025 (USD Million)
7.4 Contract Research Organizations
7.4.1 Contract research organizations market estimate & forecast, 2014 – 2025 (USD Million)
7.5 Pharmaceutical & Biotechnology Companies
7.5.1 Pharmaceutical & biotechnology companies market estimate & forecast, 2014 – 2025 (USD Million)
7.6 Others
7.6.1 Others market estimate & forecast, 2014 – 2025 (USD Million)
Chapter 8 Mycoplasma Testing Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, End-Use
8.1 Mycoplasma testing market share by region, 2017 & 2025
8.2 North America
8.2.1 U.S.
8.2.1.1 U.S. mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.2.1.2 U.S. mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.2.1.3 U.S. mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.2.1.4 U.S. mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.2.2 Canada
8.2.2.1 Canada mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.2.2.2 Canada mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.2.2.3 Canada mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.2.2.4 Canada mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.3.1.2 Germany mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.3.1.3 Germany mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.3.1.4 Germany mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.3.2 UK
8.3.2.1 UK mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.3.2.2 UK mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.3.2.3 UK mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.3.2.4 UK mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Japan mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.4.1.2 Japan mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.4.1.3 Japan mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.4.1.4 Japan mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.4.2 China
8.4.2.1 China mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.4.2.2 China mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.4.2.3 China mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.4.2.4 China mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.4.3 India
8.4.3.1 India mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.4.3.2 India mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.4.3.3 India mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.4.3.4 India mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.5 Latin America
8.5.1 Brazil
8.5.1.1 Brazil mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.5.1.2 Brazil mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.5.1.3 Brazil mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.5.1.4 Brazil mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.5.2 Mexico
8.5.2.1 Mexico mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.5.2.2 Mexico mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.5.2.3 Mexico mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.5.2.4 Mexico mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
8.6 MEA
8.6.1 South Africa
8.6.1.1 South Africa mycoplasma testing market, by product, 2014 – 2025 (USD Million)
8.6.1.2 South Africa mycoplasma testing market, by technology, 2014 – 2025 (USD Million)
8.6.1.3 South Africa mycoplasma testing market, by application, 2014 – 2025 (USD Million)
8.6.1.4 South Africa mycoplasma testing market, by end-use, 2014 – 2025 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Thermo Fisher Scientific, Inc.
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Merck KGaA
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Lonza Group Ltd.
9.1.3.1 Company overview
9.1.3.2 inancial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Promo Cell GmbH
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 American Type Culture Collection
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Charles River Laboratories International, Inc.
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Bionique Testing Laboratories, Inc.
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Biological Industries Israel Beit Haemek Ltd.
9.1.8.1 Company overview
9.1.8.2 inancial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 InvivoGen
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives


【レポート販売概要】

■ タイトル:マイコプラズマ試験の世界市場分析:製品別、技術別(PCR、ELISA、直接アッセイ、微生物培養技術)、用途別(細胞株、ウイルス、生産終了細胞試験)、エンドユーザー別、セグメント予測、2014-2025
■ 英文:Mycoplasma Testing Market Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2014-2025
■ 発行日:2017年3月9日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707563
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。